KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Capital Employed (2016 - 2026)

Amgen has reported Return on Capital Employed over the past 17 years, most recently at 15.87% for Q1 2026.

  • For Q1 2026, Return on Capital Employed rose 486.0% year-over-year to 15.87%; the TTM value through Mar 2026 reached 15.87%, up 486.0%, while the annual FY2025 figure was 13.82%, 365.0% up from the prior year.
  • Return on Capital Employed for Q1 2026 was 15.87% at Amgen, up from 14.0% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 20.44% in Q3 2022 and troughed at 8.79% in Q2 2024.
  • A 5-year average of 13.55% and a median of 12.9% in 2025 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 499bps in 2022 and later plummeted -917bps in 2023.
  • Year by year, Return on Capital Employed stood at 19.63% in 2022, then tumbled by -47bps to 10.47% in 2023, then grew by 2bps to 10.63% in 2024, then surged by 32bps to 14.0% in 2025, then rose by 13bps to 15.87% in 2026.
  • Business Quant data shows Return on Capital Employed for AMGN at 15.87% in Q1 2026, 14.0% in Q4 2025, and 12.9% in Q3 2025.